You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Colorcon
Dow
Merck
Johnson and Johnson

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Janssen Pharma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for JANSSEN PHARMA, and what generic and branded alternatives to JANSSEN PHARMA drugs are available?

JANSSEN PHARMA has five approved drugs.



Summary for Janssen Pharma
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Janssen Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma MONISTAT miconazole INJECTABLE;INJECTION 018040-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Janssen Pharma ERGAMISOL levamisole hydrochloride TABLET;ORAL 020035-001 Jun 18, 1990 DISCN No No   Start Trial   Start Trial
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 DISCN No No   Start Trial   Start Trial
Janssen Pharma NIZORAL ketoconazole CREAM;TOPICAL 019084-001 Dec 31, 1985 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Janssen Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharma NIZORAL ketoconazole CREAM;TOPICAL 019084-001 Dec 31, 1985 4,335,125   Start Trial
Janssen Pharma MONISTAT miconazole INJECTABLE;INJECTION 018040-001 Approved Prior to Jan 1, 1982 3,839,574   Start Trial
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 4,962,115   Start Trial
Janssen Pharma ERGAMISOL levamisole hydrochloride TABLET;ORAL 020035-001 Jun 18, 1990 4,584,305   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
McKesson
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.